Flexible Endoscopic Transaqueductal Fenestration of Fourth Ventricular Arachnoid Cysts Combined with Endoscopic Third Ventriculostomy: A Technical Note.

Neurol Med Chir (Tokyo)Sep 9, 2026 (epub)

Takayuki Ishikawa, Yuichi Nagata, Yugo Kishida et al.

✦ AI-curated · Sources linked

Condensed from the publisher's abstract. An xxcode editorial summary of this publication has not been generated yet.

From the abstract

Fourth ventricular arachnoid cysts are rare and optimal surgical management remains unclear. We describe a flexible endoscopic trans-third ventricular technique for the treatment of fourth ventricular arachnoid cysts associated with obstructive hydrocephalus.

Source

PubMed · PMID 42716763

Published in Neurol Med Chir (Tokyo). The text above is extracted from the publisher's own abstract and has not been edited by xxcode. For clinical decisions, review the original publication.

ShareTelegram LinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Neurosurgery

Clinical ResearchHematology

Ponatinib-Blinatumomab or Imatinib-Chemotherapy for Adult Ph-Positive ALL.

This multicenter, phase 3 randomized trial compared frontline ponatinib plus blinatumomab with imatinib plus chemotherapy in adults with Philadelphia-positive acute lymphoblastic leukemia.

N Engl J MedOct 15, 2026Read summary

Clinical ResearchHematology

Efficacy and safety of mitapivat in patients with sickle cell disease (RISE UP): a phase 3, double-blind, global, randomised, placebo-controlled trial.

RISE UP was a phase 3, double-blind, global, randomised, placebo-controlled trial conducted at 69 sites in 15 countries. It evaluated twice-daily mitapivat in patients older than 16 years with sickle cell disease…

LancetOct 24, 2026Read summary

Clinical ResearchRheumatology

Ianalumab for the Treatment of Patients with Sjögren's Disease.

Two 52-week, double-blind, randomized, placebo-controlled phase III trials evaluated monthly or less frequent ianalumab in patients with active Sjögren's disease.

N Engl J MedOct 22, 2026Read summary

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

Your specialties
Your filters and thresholds
Clinical Research + Case Reports, tuned separately
Automatic weekly delivery
Audio and text

Create my personalized digest See plans

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.